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Background: Since the discovery of adult mesenchymal stem cells extensive research has been conducted to deter-
mine their mechanisms of differentiation and effectiveness in cell therapy and regenerative medicine.
Material and Methods: To assess the efficacy of autologous dental pulp mesenchymal stem cells delivered in 
a collagen matrix for post-extraction socket healing, a single-centre, double-blind, randomised, split-mouth, 
controlled clinical trial was performed. Both impacted mandibular third molars were extracted from 32 pa-
tients. Dental pulp was collected and dissociated; the resulting cell suspension, obtained by centrifugation, was 
incorporated into a resorbable collagen matrix and implanted in 32 experimental post-extraction sockets. Co-
llagen matrices alone were implanted in 32 contralateral, control post-extraction sockets. Two neuroradiologists 
independently assessed the extent of bone repair at 6 months after the extractions. Computed tomography (CT, 
Philips Brilliance) and an advanced display platform (IntelliSpace Portal) was used to record extraction socket 
density, expressed as Hounsfield units (HU) and height (mm) of the distal interdental bone septum of the second 
molar. Measurements at 6 months post-extraction were compared with measurements obtained immediately after 
extraction. Data were analysed with the statistical program STATA 14.
Results: Two patients dropped out of the study. The final sample consisted of 22 women and 8 men (mean age, 
23 years; range: 18–30 years). Clinical, radiological, and surgical characteristics of impacted third molars of 
the control and experimental groups were homogeneous. Measurements obtained by the two neuroradiologists 
showed agreement. No significant differences were found in the extent of bone repair during analyses of density 
(p=0.4203 neuroradiologist 1; p=0.2525 neuroradiologist 2) or interdental septum height (p=0.2280 neuroradiolo-
gist 1; p=0.4784 neuroradiologist 2). 
doi:10.4317/medoral.22466
http://dx.doi.org/doi:10.4317/medoral.22466
Barbier L, Ramos E, Mendiola J, Rodriguez O, Santamaria G, Santamaria 
J, Arteagoitia I. Autologous dental pulp mesenchymal stem cells for infe-
rior third molar post-extraction socket healing: A split-mouth randomised 
clinical trial. Med Oral Patol Oral Cir Bucal. 2018 Jul 1;23 (4):e469-77.   
http://www.medicinaoral.com/medoralfree01/v23i4/medoralv23i4p469.pdf
Article Number: 22466          http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed
Scopus, Embase and Emcare 
Indice Médico Español
Med Oral Patol Oral Cir Bucal. 2018 Jul 1;23 (4):e469-77.                                                                                                Autologous pulp cells and mandibular bone defect healing: Clinical Trial
e470
Introduction
Since the discovery of adult mesenchymal stem cells 
(MSCs), extensive research has been conducted to deter-
mine their mechanisms of differentiation and effective-
ness in cell therapy and regenerative medicine. MSCs can 
be isolated from several cell extracts, and some of the 
most accessible extracts are from the oral cavity (OM-
SCs). These have been isolated from deciduous teeth, 
dental follicle, apical papilla, periosteum, dental liga-
ment (LMSCs) and dental pulp (PMSCs) (1-2). MSCs 
are multipotent stromal cells that can be safely cryo-
preserved, used with several scaffolds, and extensively 
proliferate. They have long lifespans and can build in 
vivo adult bone with Havers channels and the appropri-
ate vascularisation (3). Importantly, they can avoid the 
isolation, differentiation, expansion, and proliferation 
required in previous cell culture methods, which were 
not compatible with clinical practice due to the exten-
sive manipulation of pulp tissue and its lengthy prepara-
tion process. 
To facilitate clinical management, the Rigenera Proto-
col (Human Brain Wave srl, Torino, Italy) allows the 
production of adult mesenchymal stem cells from a 
minimum quantity of connective tissue of adult den-
tal origin. A medical device, Rigenera Machine®, and 
Rigeneracons® sterile filters can disaggregate dental 
tissue and perform the filtering necessary to promote 
the expulsion of older differentiated cells and the enrich-
ment of younger progenitor cells present within LMSC 
(4) and PMSC (5) populations. In this approach, the den-
tal tissue experiences a phase of collection, foll-owed 
by mechanical disaggregation, filtering of the MSC cell 
suspension, and immediate application to clinical prac-
tice (5). This technical procedure neither expands nor 
manipulates the resulting cells. They constitute autolo-
gous tissues, such that the patient can be both donor and 
recipient (6).
A large gap between basic and translational research 
publications is present in the literature regarding OM-
SCs, with very few reports of clinical trials and clini-
cal cases of bone or periodontal repair with LMSCs (4), 
PMSCs (5,7,8), and MSC derivatives of periosteum (9). 
To characterise the regenerative potential of autologous 
dental pulp mesenchymal stem cells (ADPMSCs) with 
the Rigenera® Protocol, we designed an independent, 
randomised, split-mouth clinical trial. We compared the 
bone healing efficacy of ADPMSCs, delivered in a re-
sorbable collagen matrix, when implanted in impacted 
inferior third molar (ITM) post-extraction sockets (ex-
perimental group, EG) against the bone healing response 
of the alveolar sockets of the contralateral impacted 
ITM in which only collagen matrix is implanted (con-
trol group, CG). We tested the null hypothesis that bone 
healing in the EG and CG behaves similarly, with a 
maximum difference in proportions of 0.4. 
Material and Methods
We designed an independent, single-centre, double-
blind, randomised, split-mouth controlled clinical trial. 
The trial was approved by the Ethical Committee of 
Clinical Investigation of Cruces University Hospital 
(Protocol number EC20141) and registered on the Eu-
draCT database (number: 2014-001913-18). It was con-
ducted in compliance with current legislation, the ethi-
cal principles of the Declaration of Helsinki, and good 
clinical practice. 
We included patients with ages ranging from 18 to 30 
years who attended the outpatient clinic of the Depart-
ment of Maxillofacial Surgery at our hospital. For all 
patients, bilateral extractions of impacted mandibular 
third molars for mechanical reasons were indicated.
Patients with systemic diseases, risk factors for bacte-
rial endocarditis, recurrent oral diseases, septic mouth, 
an infectious process, or who had undergone antibiotic 
treatment within 10 days of extraction were excluded 
from the study. Allergic patients, patients with known 
intolerance to any study medication, and pregnant or 
lactating women were also excluded from the study. Pa-
tients who showed cysts in radiographic images of either 
ITM, and those with possible roots in the inferior dental 
canal, were also excluded. All excluded patients were 
removed prior to randomisation. Patients who chose to 
drop out of the clinical trial, as well as those who were 
not followed-up, were excluded post-randomisation.
Sample size was calculated prior to the start of the study 
with the statistical software STATA 14 (StataCorp LP, 
College Station, TX, USA). Based on previous research 
studies, we assumed that post-extraction physiological 
bone resorption may reach 50% (10); thus, we considered 
it clinically relevant to assess whether resorption could 
be reduced to 10% by using the proposed ADPMSC 
treatment. A sample of 30 patients was required to com-
pare the hypothesis with a 1-type error of 0.05 and 80% 
power for a difference in proportions of ≥0.4, assuming 
possible losses of 10% (33 patients).
Consecutive patient sampling was performed. Patients 
Conclusions: In our clinical trial, we were unable to demonstrate that autologous dental pulp mesenchymal stem cells 
reduce socket bone resorption after inferior third molar extraction.
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who met the inclusion criteria were asked to sign the 
informed consent form in order to participate in the 
clinical trial. Extraction sockets assigned to the EG were 
treated with ADPMSC, prepared according to the Rigen-
era® Protocol, incorporated into an absorbable lyophi-
lised collagen matrix Hemo-Klee® (Directive 93/42 
EEC. Euroklee S.L. Cerdañola del Valles Barcelona, 
Spain), whereas those assigned to the CG were treated 
with collagen matrix alone. The decision of which sock-
et (left or right) received the ADPMSC treatment was 
made with codes generated by an independent profes-
sional, who used randomisation software. The indepen-
dent professional concealed the allocations in sealed 
and sequentially numbered envelopes. A maxillofacial 
surgeon (MS1) performed the standardised procedure 
for both third molar extractions. A second maxillofacial 
surgeon (MS2) prepared and implanted ADPMSCs in 
the EG and collagen matrix in the CG, then sutured the 
flaps. MS2, who did not participate in the analysis of 
the results, was the only non-blinded researcher in this 
study.
To assess the bone repair achieved, at 6 months after 
ITM extraction, two CT scans were performed (Phil-
ips Brilliance 16; Philips HealthSystems, Amsterdam, 
Netherlands): one on the day of the surgery (t0) and the 
other 6 months later (t6). Socket density (in Hounsfield 
units, HU) and resorption response (in height, mm, of 
the interdental distal septum to the second molar) were 
assessed. Response variables were bone density (BDD) 
and bone resorption (BRS). BDD was assessed by sub-
tracting the final average socket density (measured in a 
region of interest in the lower half of the socket at t6) 
from the initial average density measured in the same 
area at t0 (Fig. 1). 
Fig. 1: Top image t0 in multiplanar format, with windows for bone density assess-
ment in intact post-extraction sockets. Average densities are measured in the lower 
half of both sockets. Bottom image t6, with alveolar repair on both sides.
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BRS was assessed by calculating the mean height (mm) 
of the interdental distal septum to the second molar at 6 
months and the mean height recorded immediately after 
the extraction (Fig. 2).
Fig. 2: Results at day t0. Images in multiplanar format with windows for bone 
density assessment. Measurements of left post-extraction cavity were made 
in the three planes, represented by the area in red colour.
-Procedure
During the first contact with patients who could be re-
cruited for the clinical trial, MS1 studied possible can-
didates. Bilateral impaction of both ITM and gingival 
coverage (enabling flap closure without tensions) were 
confirmed radiologically and clinically, respectively. 
The inexistence of any possible reason for exclusion was 
assessed in the clinical history. Patients were provided 
with information regarding the surgical procedure and 
clinical trial. The informed consent form was explained 
to them and they were each provided with a copy.
During the second visit, the surgical procedures were 
performed after repeat confirmation that patients met 
the inclusion criteria and had signed the informed con-
sent form. Patients were then assigned a sequential pa-
tient number. During this second appointment, we also 
recorded data regarding demographic, clinical, radio-
logical, and surgical variables. 
Demographic variables included age (corresponding to 
the age of the patient on the day of the intervention), 
sex (male or female), and ethnicity (Caucasian, Black, 
Asian, others) of patients. Clinical and radiological vari-
ables included the use of contraceptives (response: yes 
or no) in the last month, the use of psychotropic drugs 
(response: yes or no) and whether they were taken in the 
last month, and tobacco smoking (expressed as number 
of cigarettes per day at the time of the intervention).
After the local anaesthetic nerve block was performed, 
a millimetre periodontal probe (SM 13 Bontempi®) of 
thickness 0.5–11.5 mm was used to record the depth 
(mm) at three points distal to the second molar in both 
ITMs. The ITM was classified as type I when the crown 
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showed no bone coverage on radiographic analysis and 
clinical analysis showed that the gingival coverage 
would allow flap closure without tensions; as type II 
when the crown was partly covered by bone and gum; 
and as type III when the third molars were fully covered 
by bone and gum. 
The angulation and depth of the impacted mandibular 
third molars were determined by using the classifica-
tions of Pell & Gregory and Winter (11). All opera-
tions were performed by the same maxillofacial sur-
geon (MS1) with a standardised procedure for both 
third molars, beginning on the right side in all cases. 
The mouth was previously rinsed with for 20 sec with 
Lacer® 0.12% chlorhexidine mouthwash (Lacer S.A. 
Cerdañola del Vallés, Barcelona, Spain). Local and re-
gional anaesthesia were performed with 3.6 ml articaine 
(Ultracain®; Normon S.A. Tres Cantos, Madrid, Spain) 
and epinephrine (40/0.01 mg/mL) for blocking inferior 
alveolar and buccal nerves. A full thickness mucoperi-
osteal flap was elevated and reflected. The incision was 
made with a No. 15 surgical scalpel blade, forming an 
envelope flap that extended from the mesial aspect of 
the second molar to the ramus, with lateral divergence 
of the posterior extension. Bone removal and tooth sec-
tioning were performed by using a hand piece with a 
round bur and saline irrigation. After the extraction, 
the sockets were debrided and necrotic tissue was re-
moved. The area was irrigated with 3 ml 0.12% Lacer® 
chlorhexidine and saline solution for 1 min (11).
MS1, who performed the extractions, did not con-
sider which groups (EG or CG) patients belonged to. 
Subsequently, after extracting each ITM, MS2 placed 
the ITM in a tray with sterile gauze soaked in 0.12% 
chlorhexidine for 2 min. By using a round bur, hand 
piece, and saline irrigation, an indentation was made 
in the enamel-cementum line, which gradually be-
came a groove. When the groove was sufficiently 
deep, odontosection of the molars was completed by 
pressing with a chisel, thereby providing access to 
the pulp chamber. The pulp from both pulp chambers 
was collected with a sterile curette and deposited in 
a Rigeneracons® capsule; then, 1 mL saline solution 
was added. The capsule was agitated for 1 min in the 
Rigenera® Machine. MS2 collected the PMSC suspen-
sion by aspiration with a syringe, incorporated it into the 
collagen matrix Hemo-Klee®, left it standing for 8 min, 
and implanted it in the left or right socket after opening 
the randomisation envelope. The collagen matrix was 
exclusively implanted contralaterally with 1 mL saline 
solution. Lastly, flap closure was performed with a 3/0 
absorbable suture, ensuring complete flap closure to 
avoid alveolar permeability. An Augmentine® 875/125 
mg tablet (GlaxoSmithKline S.A. Tres Cantos, Madrid, 
Spain) was prescribed to all patients 1 h before the ex-
tractions. They also received a prescription of one tablet 
every 8 h for another 5 days to limit possible infectious 
and inflammatory complications. All patients were ad-
ministered Enantyum® 25 mg film-coated tablets (Me-
narini SA, Badalona, Barcelona, Spain) every 8 h until 
complete remission of pain, and performed rinsing with 
Lacer® 0.12% chlorhexidine mouthwash every 8 h for 
7 days.
Surgical variables recorded include the surgical time, 
tooth sectioning, and ostectomy. Surgical time was mea-
sured by using a stopwatch from the first incision until 
the last suture was completed. Tooth sectioning was re-
corded as yes or no. No pulp cavity was invaded during 
the extraction. With regards to ostectomy, a score of 0 
was assigned when ostectomy was unnecessary; 1/3 was 
assigned when ostectomy was necessary to uncover the 
crown; and 2/3 was assigned when ostectomy was per-
formed to uncover the crown and part of the root.
Written postoperative instructions were distributed. A 
24-hour telephone number and a clinical trial participation 
card were also provided. Immediately after the extractions, 
multi-slice CT scanning without contrast was performed 
with the Phillips Brilliance 16-slice CT scanner (Phillips, 
Amsterdam, Netherlands) at the Department of Radio-
logy, with low energy, low power, and an exposure time of 
seconds with high image quality. The following technical 
characteristics were used: 1 mm slice thickness, 16 × 
0.75 degree of collimation, 178 mm field of view (FOV), 
512 × 512 matrix, 90 kV dose, 100 mAs, Level iDose 3, 
6 mGy volume CT dose index (CTDI), according to the 
standard “As low as reasonably achievable.”ALARA. 
From this CT scan, two neuroradiologists, who did not 
know whether the socket was for a patient in the EG or 
CG, independently made the following measurements 
with the advanced analysis platform IntelliSpace Portal 
(Phillips, Amsterdam, Netherlands): 
1.-  Residual volume of both extraction sockets (mm3) 
on the day of extraction t0: three diameters, namely the 
latero-lateral (LL), anteroposterior (AP), and craniocau-
dal (CC) diameters, were measured. The volume was 
calculated by using the formula LL × AP × CC/2 (Fig. 
3). This volume was used to analyse the homogeneity 
between the CG and EG.
2.- Density (HU) of the residual sockets: this was assessed 
by using the mean of measurements taken in one region of 
interest (Fig. 1).
 3.- Bone resorption: This was assessed by measuring 
the height (mm) from the occlusal plane to the highest 
point of the interdental septum distal to the second mo-
lar (Fig. 2).
During the third appointment, at 6 months after the 
intervention, a second CT scan was performed, in the 
same manner as the original scan. Both neuroradiolo-
gists, who did not know which sockets were treated 
with the ADPMSC suspension, independently assessed 
the variable response, including the density (HU) of the 
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Fig. 3: Distal interdental septum of the second molar at t0 and t6. Images ac-
quired by using bone windows. Measurement of distal interdental septum height 
(mm) in second molars at the times t0 and t6.
regenerated alveolus and the bone resorption of the in-
terdental septum distal to the second molar (mm).
The values of the clinical, demographic, radiological, 
and surgical variables of the 64 ITMs from the CG and 
EG were recorded in an Excel spreadsheet. The values 
assessed by each neuroradiologist for each measure-
ment, immediately after the surgery (t0, volume, den-
sity, and height) and 6 months after the surgery (t6, 
density and height) were also recorded. Adverse events 
were recorded.
Quantitative variables were assessed by their mean 
values while qualitative variables were assessed by 
calculating absolute frequencies. The homogeneity of 
ITM characteristics from the CG and EG were assessed 
by chi-squared tests, Fisher’s exact tests, and analysis 
of variance, depending on the nature of the variables 
(qualitative or quantitative). Inter-observer agreements 
(between neuroradiologists 1 and 2) of variables (volu-
me, density, and height) recorded immediately after the 
surgery, and of response variables BRS and BDD, were 
assessed by using the mean Kendall rank correlation 
coefficient. To analyse the response variables BRS and 
BDD, we assessed fit-to-normality with the Shapiro-
Wilk Test. We tested the null hypothesis of no differ-
ence in reparative response between the EG and CG, by 
using the t-test when the variable followed a normal dis-
tribution, and by Mann-Whitney U test when the vari-
able did not follow a normal distribution. Significance 
level was pre-set to 0.05. Stata14 (StataCorp LP, College 
Station, TX, USA) was the statistical software used.
Results
Recruitment began in March 2015. The first patient un-
derwent extractions in May 2015 and the last patient 
underwent extractions in February 2017. In total, 32 pa-
tients were recruited; two were excluded because they 
were unable to undergo a CT scan at 6 months after the 
extraction. The final sample consisted of 30 patients and 
60 molars (30 in the EG and 30 in the CG). 
Because this was a split-mouth study, demographic 
variables were identical for the ITMs from the EG and 
CG. The patients were Caucasian, eight men and 22 
women. Their mean age was 23 years (range: 18–30 
years). Seven patients were taking contraceptives, one 
was undergoing treatment with psychotropic drugs, 
four patients smoked < 10 cigarettes per day, and five 
smoked 10–20 cigarettes per day.
No significant differences in clinical, radiological, and sur-
gical characteristics of ITMs were found between the CG 
and EG (Table 1). We concluded that there was an agree-
ment between the independent observations of the two 
neuroradiologists in the records analysed (Table 2). We 
analyse the normality-adjusted values of response vari-
ables, BDD and BRS, assessed by both neuroradiologists. 
Bone repair, in terms of BDD and BRS, showed no sig-
nificant differences between the control and experimental 
groups, either when analysing density (BDD: p=0.4203 
neuroradiologist 1; p=0.2525 neuroradiologist 2) or when 
analysing the interdental septum height (BRS: p=0.2280 
neuroradiologist 1; p=0.4784 neuroradiologist 2) (Table 3).
No morbidity was observed during the clinical trial, and 
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VARIABLE mean CG EG P-value
Periodontal probe (mm) 6.267857 6.321429 6.214286 0.7992*
Type of inclusion Type 1: 5, Type II: 21,
Type III: 4
Type 1: 5, Type II: 20,
Type III: 5
0.82**
Angulation Distal: 2, Horizontal: 0, Mesial: 8, 
Vertical: 20
Distal: 2, Horizontal: 1, Mesial: 
6, Vertical: 21
0.905 **
Surgery time (s) 2385.667 2377 2394.33 0.9527 *
Odontosection No: 23, yes: 7 No: 22, yes: 8 0.99 **
Ostectomy 0: 3, 1/3: 24, 2/3: 3 0: 2, 1/3: 25, 2/3: 3 0.588 **
Bone volume (mm3) 
observer 1
762.9833 741.2000 784.7667 0.5436*
Bone volume (mm3) 
observer 2
769.1167 754.9333 783.3000 0.7028*
Table 1: Homogeneity between study groups.
CG: Control group, EG: Experimental group, No: number of patients who did not undergo odontosection, Yes: number of patients who under-
went odontosection, 0: number of patients in whom ostectomy was unnecessary, 1/3: number of patients in whom ostectomy was necessary 
to uncover the crown, 2/3: number of patients in whom ostectomy was performed to uncover the crown and part of the root. *Student’s t-test, 
**Fisher’s exact test. No significant differences between the characteristics of third molars in the CG and EG were found.
Variable / time/ observer Tau-a p
Assessment of agreement in height (mm) between the two observers immediately 
after the surgery
0.5282 0.0000
Assessment of agreement in density (Hounsfield units, HU) between the observers 
immediately after the surgery 
0.3136 0.0004
Assessment of agreement in volume (mm3) between the observers immediately after 
the surgery 
0.3198 0.0003
Assessment of agreement in height (mm) between the observers at 6 months after the 
surgery.
0.4497 0.0000
Assessment of agreement in density (Hounsfield units, HU) between the observers at 
6 months after the surgery.
0.6565 0.0000
Assessment of agreement in bone resorption between the observers 0.2915 0.0008
Assessment of agreement in bone density between the observers 0.6328 0.0000
Table 2: Inter-observer agreement in this study.
Kendall rank correlation coefficient, Tau-a value higher than 0 shows correlation between the two neuroradiologists. Because the 
p-value is lower than or equal to a significance level of 0.05, the null hypothesis of random agreement between neuroradiologists is 
discarded; thus, the ratings are associated with each other.
no information was gathered from other studies that 
discouraged continuation of the trial.
Discussion
This manuscript was written in accordance with the rec-
ommendations of the CONSORT 2010 Declaration (12). 
Our objective was to assess the effect of ADPMSCs on 
limiting socket bone resorption after ITM extraction.
Regenerative medicine aims to repair damaged tissues 
with cell therapy procedures. It is based on the use of 
stem cells from different origins; these cells can be dif-
ferentiated into specific mesenchymal tissues by using 
different procedures. Adult dental pulp stem cells are one 
of the sources used in the repair and regeneration of bone 
and periodontal and dental defects. One of the limitations 
of application to clinical practice could be the prolonged 
time between the collection of dental pulp and isolation 
of PMSCs, which likely explains why few clinical trials 
are registered in the European Medicines Agency (www.
ema.europa.eu) and in the National Institutes of Health 
of the United States of America (https://www.nih.gov).
In an experimental animal model, D’Aquino et al. de-
monstrated the capacity of a suspension of digested 
dental pulp cells, cultured in a low-density liquid, to 
induce osteogenesis, angiogenesis, and vascularization 
of bone tissue (13). The same research team simplified 




n Mean Mean Std. Dev. Min, Max p-value
(BDD1)
CG




30 507.8000 353.8970 6, 1352
(BDD2)
CG
30 534.6167 580.3667 293.5901 113, 1130 0.2525*
(BDD2)
EG
30 488.8667 319.1284 -24, 1053
(BRS1) 
CG









1.1898 -2.7, 2 0.4784*
(BRS1) 
EG
30 -0.2966 1.5678 -3.7, 3
Table 3: Analysis of the response variable, density, and height between the experimental group with autologous dental pulp mes-
enchymal stem cells (ADPMSCs) and the control group without ADPMSCs
*t-test (parametric) and **Mann-Whitney U test (non-parametric). These tests were used in accordance with the fit to normal-
ity of the response variable. BDD (bone density): The records of mean density (Hounsfield units, HU) assessed in one region of 
interest in the lower half of the socket at 6 months after the surgery, and the mean density assessed in the same region of interest 
of the residual cavity immediately after extraction, by both neurologists, were analysed in both experimental (EG) and control 
(CG) groups. BRS (bone resorption): The records of mean height (mm) of the interdental distal septum to the second molar at 6 
months after extraction and the mean height (mm) recorded after the extraction of both neuroradiologists, were analysed in EG 
and CG. ADPMSC: autologous dental pulp mesenchymal stem cells. BDD1: Bone density recorded by observer 1, BDD2: Bone 
density recorded by observer 2, BRS1: Bone resorption recorded by observer 1, BRS2: Bone resorption recorded by observer 2. 
No significant differences were found in any of these comparisons.
the procedure by demonstrating the capacity to produce 
bone nodules, without the requirement for prior expan-
sion of PMSCs, in an experimental animal model (14). 
A controlled split-mouth clinical trial was published 
regarding bone repair in post-extraction sockets of the 
ITM in seven patients. To collect pulp tissue, the upper 
third molars were removed; pulp cells were mechani-
cally dissociated, filtered, and cultured. After 21 days 
of culture, ADPMSCs were obtained and, by using a 
collagen matrix, these cells were implanted in the ex-
perimental post-extraction socket of the ITM; collagen 
alone was implanted in the control socket. Consequent-
ly, bone regeneration was higher by 25% in the experi-
mental group (7). 
A study conducted three years later on the same samples 
concluded that the regenerated bone in the ADPMSC 
group was evenly vascularised and more compact than 
that in the control group, where a collagen sponge alone 
was implanted (8). Following these preliminary stud-
ies, the Rigenera® Protocol was developed and applied 
clinically (4,5,6,9). ADPMSCs obtained from dental lig-
ament-derived tissue were added to a collagen sponge 
and implanted in the post-extraction cavity of an ITM; 
the contralateral cavity was implanted with collagen 
alone. After 6 months, clinical beginning/ending differ-
ences were noted in probing at the experimental site (12 
mm/3 mm), compared with the control site (11 mm/7 
mm) (4). A report of a case where the sinus cavity was 
filled with grafted ADPMSCs indicated that the den-
sity of the newly formed bone was approximately twice 
that of the native bone (5). Application of the protocol 
to adult periosteal tissue demonstrated that progenitor 
cells for use in tissue regeneration could be produced 
(6). In a subsequent controlled multi-centre clinical trial 
of 35 patients, a suspension of autologous periosteal 
progenitor cells was grafted with a collagen matrix in 
the post-extraction socket; outcomes in these patients 
were compared with those in a control group where col-
lagen alone was used. That study demonstrated that the 
autologous periosteal progenitor cells accelerated ossi-
fication and reduced bone reabsorption in the alveolar 
crest, thus preserving the socket (9).
By using the Rigenera® Protocol, we have analysed the 
ability of ADPMSCs to limit bone resorption in a model 
of ITM extraction, which is frequently used to assess 
the efficacy of anti-inflammatory and analgesic medi-
cines. For this purpose, we conducted an independent 
clinical trial with a double-blind design, strict randomi-
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sation, and analysis of the inter-observer agreement of 
response variables, thereby providing solid internal va-
lidity. The image-measuring instrument used was the 
advanced display platform IntelliSpace Portal, which 
generates actual measurements of bone density and in-
terdental septum height. 
Recruitment was slower than expected due to the need 
to extract ITMs from each of the patients who had simi-
lar clinical and radiological characteristics. We recruit-
ed young patients aged between 18 and 30 years, from 
a healthy population, to minimise a possible effect of a 
decreased frequency of mesenchymal stem cells with 
age (15). When third molars are included, the pulp col-
lected from the pulp chamber is, theoretically, free of 
disease. The split-mouth model allowed each patient to 
have control. The ADPMSC suspension was delivered 
in a collagen matrix, which is the most commonly used 
vehicle in this type of research (16). 
The limitations of our clinical trial include the narrow 
age range, from 18 to 30 years. Furthermore, we did not 
perform immunohistochemical studies on the newly 
formed tissue, and we only evaluated the results once, 
at 6 months after surgery. A recent systematic review 
found some standardisation gaps in the method of isola-
tion of stem cells from the oral cavity and stated that 
methodological heterogeneity should be assessed to cre-
ate a protocol standardising their isolation and differen-
tiation (2). We agree with the findings of the systematic 
review.
Within the context of the aforementioned limitations, 
we were not able to demonstrate that autologous dental 
pulp mesenchymal stem cells have the ability to limit 
socket resorption after impacted lower third molar ex-
traction.
Source of Funding: Project PI13/00541, funded by Ins-
tituto de Salud Carlos III and co-funded by European 
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